Angiogenesis and vasculopathy in systemic sclerosis: Evolving concepts

Current Rheumatology Reports

Volumn 14, Issue 1, 2012, Pages 56-63

  Rabquer, Bradley J ^a   Koch, Alisa E ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Endothelial cells; Scleroderma; Systemic sclerosis; Vasculogenesis; Vasculopathy

Indexed keywords

BETA THROMBOGLOBULIN; CHEMOKINE RECEPTOR CX3CR1; CXCL1 CHEMOKINE; CXCL16 CHEMOKINE; ENDOSTATIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; EPHRIN RECEPTOR B2; EPHRIN RECEPTOR B4; FIBROBLAST GROWTH FACTOR 2; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; JUNCTIONAL ADHESION MOLECULE A; KALLIKREIN; KALLIKREIN 11; KALLIKREIN 12; KALLIKREIN 9; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR; STROMAL CELL DERIVED FACTOR 1; THROMBOCYTE FACTOR 4; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UROKINASE RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME REGULATION; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SYSTEMIC SCLEROSIS; TRANSCRIPTION REGULATION; VASCULAR DISEASE;

HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PERIPHERAL VASCULAR DISEASES; SCLERODERMA, SYSTEMIC;

EID: 84857042496     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-011-0219-1     Document Type: Article

References (50)

1. A Gabrielli EV Avvedimento T Krieg 2009 Scleroderma N Engl J Med 360 19 1989 2003 19420368 10.1056/NEJMra0806188 1:CAS:528:DC%2BD1MXls1ShsLw%3D This is an excellent recent review on the pathogenesis of SSc.
2. HR Maricq 1981 Wide-field capillary microscopy Arthritis Rheum 24 9 1159 1165 7306237 10.1002/art.1780240907 1:STN:280:DyaL38%2FmvVKhtA%3D%3D (Pubitemid 11057343)
3. SN Lambova U Muller-Ladner 2010 Capillaroscopic pattern in systemic sclerosis-an association with dynamics of processes of angio- and vasculogenesis Microvasc Res 80 3 534 539 20654632 10.1016/j.mvr.2010.07.005
4. E Hachulla P Clerson D Launay, et al. 2007 Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study J Rheumatol 34 12 2423 2430 17985402 (Pubitemid 350230666)
5. S Lambova U Muller-Ladner 2010 Pulmonary arterial hypertension in systemic sclerosis Autoimmun Rev 9 11 761 770 20601197 10.1016/j.autrev.2010.06. 006
6. A Campo SC Mathai J Le Pavec, et al. 2010 Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension Am J Respir Crit Care Med 182 2 252 260 20339143 10.1164/rccm.200912-1820OC
7. CP Denton G Lapadula L Mouthon U Muller-Ladner 2009 Renal complications and scleroderma renal crisis Rheumatology (Oxford) 48 Suppl 3 iii32 iii35 10.1093/rheumatology/ken483
8. Au K, Singh MK, Bodukam V et al.: Atherosclerosis in systemic sclerosis-a systematic review and meta analysis. Arthritis Rheum 2011, Epub ahead of print.
9. M Peichev AJ Naiyer D Pereira, et al. 2000 Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors Blood 95 3 952 958 10648408 1:CAS:528: DC%2BD3cXotV2gsA%3D%3D (Pubitemid 30062717)
10. M Manetti S Guiducci L Ibba-Manneschi M Matucci-Cerinic 2010 Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis J Cell Mol Med 14 6A 1241 1254 20132409 10.1111/j.1582-4934.2010. 01027.x 1:CAS:528:DC%2BC3cXhtVGksLrF
11. M Kuwana Y Okazaki H Yasuoka, et al. 2004 Defective vasculogenesis in systemic sclerosis Lancet 364 9434 603 610 15313361 10.1016/S0140-6736(04)16853- 0 1:CAS:528:DC%2BD2cXmslaltrY%3D (Pubitemid 39094178)
12. Y Allanore F Batteux J Avouac, et al. 2007 Levels of circulating endothelial progenitor cells in systemic sclerosis Clin Exp Rheumatol 25 1 60 66 17417992 1:STN:280:DC%2BD2s3htlOmtg%3D%3D (Pubitemid 46477487)
13. J Avouac F Juin J Wipff, et al. 2008 Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity Ann Rheum Dis 67 10 1455 1460 18174219 10.1136/ard.2007.082131 1:STN:280:DC%2BD1crpvFOmsA%3D%3D
14. N Del Papa N Quirici D Soligo, et al. 2006 Bone marrow endothelial progenitors are defective in systemic sclerosis Arthritis Rheum 54 8 2605 2615 16868984 10.1002/art.22035 (Pubitemid 44205023)
15. JH Distler Y Allanore J Avouac, et al. 2009 EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells Ann Rheum Dis 68 2 163 168 18653485 10.1136/ard.2008.091918 1:STN:280: DC%2BD1M%2FmsV2mug%3D%3D
16. C Urbich S Dimmeler 2004 Endothelial progenitor cells: characterization and role in vascular biology Circ Res 95 4 343 353 15321944 10.1161/01.RES. 0000137877.89448.78 1:CAS:528:DC%2BD2cXmsVKlurs%3D (Pubitemid 39100452)
17. K Jujo M Ii DW Losordo 2008 Endothelial progenitor cells in neovascularization of infarcted myocardium J Mol Cell Cardiol 45 4 530 544 18755197 10.1016/j.yjmcc.2008.08.003 1:CAS:528:DC%2BD1cXhtlSgsrrN
18. Y Yamaguchi Y Okazaki N Seta, et al. 2010 Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis Arthritis Res Ther 12 6 R205 21050433 10.1186/ar3180 This was the first study to describe monocytic EPCs in SSc. The report further demonstrates that vasculogenesis is impaired in SSc and shows how monocytic EPCs may play a role in angiogenesis.
19. MJ Kaminski S Majewski S Jablonska M Pawinska 1984 Lowered angiogeneic capability of peripheral blood lymphocytes in progressive systemic sclerosis (scleroderma) J Invest Dermatol 82 3 239 243 6199433 10.1111/1523-1747. ep12260139 1:STN:280:DyaL2c7jslSqtw%3D%3D (Pubitemid 14197335)
20. S Majewski E Skopinska-Rozewska S Jablonska, et al. 1985 Modulatory effect of sera from scleroderma patients on lymphocyte-induced angiogenesis Arthritis Rheum 28 10 1133 1139 2413869 10.1002/art.1780281009 1:STN:280:DyaL28%2FisFKqsQ%3D%3D (Pubitemid 16250649)
21. AE Koch PJ Polverini SJ Leibovich 1986 Induction of neovascularization by activated human monocytes J Leukoc Biol 39 233 238 2416860 1:STN:280: DyaL28%2FoslKktA%3D%3D (Pubitemid 16208554)
22. M Marczak S Majewski E Skopinska-Rozewska, et al. 1986 Enhanced angiogenic capability of monocyte-enriched mononuclear cell suspensions from patients with systemic scleroderma J Invest Dermatol 86 4 355 358 2427611 10.1111/1523-1747.ep12285572 1:STN:280:DyaL28zgsF2qug%3D%3D (Pubitemid 16050008)
23. MB Kahaleh F DeLustro W Bock EC LeRoy 1986 Human monocyte modulation of endothelial cells and fibroblast growth: possible mechanism for fibrosis Clin Immunol Immunopathol 39 2 242 255 3516470 10.1016/0090-1229(86)90088-7 1:CAS:528:DyaL28XktVCru7s%3D (Pubitemid 16101509)
24. Liakouli V, Cipriani P, Marrelli A et al.: Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun Rev 2011.
25. F Margheri S Serrati A Lapucci, et al. 2010 Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12 Arthritis Rheum 62 8 2488 2498 20506099 10.1002/art.27522 1:CAS:528:DC%2BC3cXhtFOhsr%2FM This excellent study expanded on the observation that MMP-12 and pentraxin 3 are overexpressed in SSc by performing an in vitro analysis of their role in angiogenesis. The authors showed that overexpressing both molecules in healthy ECs resulted in an inhibition of angiogenesis. They also found that SSc ECs do not mount an angiogenic response to bFGF or VEGF.
26. Z Mackiewicz A Sukura D Povilenaite, et al. 2002 Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin Clin Exp Rheumatol 20 5 641 646 12412194 1:STN:280:DC%2BD38nlt1SmsQ%3D%3D (Pubitemid 35243776)
27. O Distler JH Distler A Scheid, et al. 2004 Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis Circ Res 95 1 109 116 15178641 10.1161/01.RES.0000134644.89917.96 1:CAS:528:DC%2BD2cXlt1Cru7Y%3D (Pubitemid 38931842)
28. CA Davies M Jeziorska AJ Freemont AL Herrick 2006 The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis Hum Pathol 37 2 190 197 16426919 10.1016/j.humpath.2005.10.007 1:CAS:528:DC%2BD28XlvVKqug%3D%3D (Pubitemid 43099839)
29. MT Carulli VH Ong M Ponticos, et al. 2005 Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation Arthritis Rheum 52 12 3772 3782 16320328 10.1002/art.21396 1:CAS:528:DC%2BD28XjvF2isg%3D%3D (Pubitemid 41798215)
30. BJ Rabquer P Tsou Y Hou, et al. 2011 Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis Arthritis Res Ther 13 1 R18 21303517 10.1186/ar3242 1:CAS:528: DC%2BC3MXjtVWis7w%3D This study provides further evidence of the importance of determining the expression of both angiogenic mediators and their receptors. It demonstrated that while antiangiogenic chemokines are elevated in SSc, their receptor is downregulated, thus limiting their impact.
31. P Cipriani A Franca Milia V Liakouli, et al. 2006 Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenetic implications Arthritis Rheum 54 9 3022 3033 16948134 10.1002/art.22047 1:CAS:528: DC%2BD28XhtFWksLbI (Pubitemid 44497784)
32. BJ Rabquer G Boychev JH Ruth, et al. 2010 Soluble junctional adhesion molecule-A promotes angiogenesis in rheumatoid arthritis Arthritis Rheum 62 S590 10.1002/acr.20005
33. Y Hou BJ Rabquer ML Gerber, et al. 2009 Junctional adhesion molecule-A is abnormally expressed in diffuse cutaneous systemic sclerosis skin and mediates myeloid cell adhesion Ann Rheum Dis 69 1 249 254 10.1136/ard.2008.102624
34. MU Naik SA Mousa CA Parkos UP Naik 2003 Signaling through JAM-1 and alphavbeta3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alphavbeta3 complex Blood 102 6 2108 2114 12750158 10.1182/blood-2003-04-1114 1:CAS:528:DC%2BD3sXntlKrsrk%3D (Pubitemid 37122387)
35. S D'Alessio G Fibbi M Cinelli, et al. 2004 Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis Arthritis Rheum 50 10 3275 3285 15476218 10.1002/art.20562 (Pubitemid 39372005)
36. B Giusti G Fibbi F Margheri, et al. 2006 A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients Arthritis Res Ther 8 4 R115 16859528 10.1186/ar2002
37. S Serrati M Cinelli F Margheri, et al. 2006 Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor J Pathol 210 2 240 248 16917801 10.1002/path.2048 1:CAS:528:DC%2BD28XhtFWgur%2FK (Pubitemid 44463939)
38. M Manetti Y Allanore L Revillod, et al. 2011 A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis Arthritis Rheum 63 1 247 256 20967855 10.1002/art.30101 1:CAS:528:DC%2BC3MXitVeqtrw%3D
39. RA Dean JH Cox CL Bellac, et al. 2008 Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR + CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx Blood 112 8 3455 3464 18660381 10.1182/blood-2007-12-129080 1:CAS:528:DC%2BD1cXht1OmurrJ
40. B Giusti S Serrati F Margheri, et al. 2005 The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis Arthritis Rheum 52 11 3618 3628 16255054 10.1002/art.21383 1:CAS:528:DC%2BD2MXht1KrurzM (Pubitemid 41612233)
41. F Margheri M Manetti S Serrati, et al. 2006 Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells Arthritis Rheum 54 12 3926 3938 17133606 10.1002/art.22263 1:CAS:528:DC%2BD2sXktlaltw%3D%3D (Pubitemid 44955896)
42. EF Wagner 2010 Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun) Ann Rheum Dis 69 Suppl 1 i86 i88 19995753 10.1136/ard.2009.119396 1:CAS:528:DC%2BC3cXhtFOltrk%3D
43. R Eferl R Zenz HC Theussl EF Wagner 2007 Simultaneous generation of fra-2 conditional and fra-2 knock-out mice Genesis 45 7 447 451 17607691 10.1002/dvg.20311 1:CAS:528:DC%2BD2sXhtVWiu7nF (Pubitemid 47221805)
44. R Eferl P Hasselblatt M Rath, et al. 2008 Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1 Proc Natl Acad Sci USA 105 30 10525 10530 18641127 10.1073/pnas.0801414105 1:CAS:528:DC%2BD1cXpsVGrtbs%3D
45. B Maurer N Busch A Jungel, et al. 2009 Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis Circulation 120 23 2367 2376 19933934 10.1161/CIRCULATIONAHA.109.855114 1:CAS:528:DC%2BD1MXhsVOhtrfP This study showed that mice overexpressing Fra-2 show both fibrotic and vascular characteristics of SSc. In addition, the study showed that Fra-2 is overexpressed in SSc ECs. The authors also demonstrated that blocking Fra-2 in ECs enhances VEGF-mediated angiogenesis in vitro. In all, this study established Fra-2 as an angiogenic transcription factor and demonstrated that Fra-2 transgenic mice may be an excellent model of SSc.
46. N Reich B Maurer A Akhmetshina, et al. 2010 The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis Arthritis Rheum 62 1 280 290 20039427 10.1002/art.25056 1:CAS:528: DC%2BC3cXhtFGnurfF
47. DD Spyropoulos PN Pharr KR Lavenburg, et al. 2000 Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor Mol Cell Biol 20 15 5643 5652 10891501 10.1128/MCB.20.15.5643-5652.2000 1:CAS:528:DC%2BD3cXlt1SnurY%3D (Pubitemid 30482898)
48. F Liu M Walmsley A Rodaway R Patient 2008 Fli1 acts at the top of the transcriptional network driving blood and endothelial development Curr Biol 18 16 1234 1240 18718762 10.1016/j.cub.2008.07.048 1:CAS:528:DC%2BD1cXhtVamtrbJ
49. M Kubo J Czuwara-Ladykowska O Moussa, et al. 2003 Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin Am J Pathol 163 2 571 581 12875977 10.1016/S0002-9440(10)63685- 1 1:CAS:528:DC%2BD3sXmslSnsLg%3D (Pubitemid 36909419)
50. Y Asano L Stawski F Hant, et al. 2010 Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy Am J Pathol 176 4 1983 1998 20228226 10.2353/ajpath.2010.090593 1:CAS:528:DC%2BC3cXltlels7k%3D This novel study expanded on the finding that Fli1 is decreased in SSc ECs by generating mice with Fli1 conditionally knocked out on ECs. The mice exhibited an "SSc-like" phenotype and implicated a role for Fli1 in the vascular pathology of SSc. In addition, the murine model has the potential to serve as a model of SSc vascular disease.